HomeVIRX • NASDAQ
add
Viracta Therapeutics Inc
Previous close
$0.23
Day range
$0.23 - $0.24
Year range
$0.20 - $1.31
Market cap
9.20M USD
Avg Volume
338.14K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 9.59M | -22.98% |
Net income | -9.83M | 21.26% |
Net profit margin | — | — |
Earnings per share | -0.25 | 21.88% |
EBITDA | -9.49M | 23.02% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 30.00M | -58.92% |
Total assets | 31.32M | -59.25% |
Total liabilities | 28.65M | -20.58% |
Total equity | 2.67M | — |
Shares outstanding | 39.42M | — |
Price to book | -3.33 | — |
Return on assets | -65.99% | — |
Return on capital | -93.23% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -9.83M | 21.26% |
Cash from operations | -9.83M | -22.99% |
Cash from investing | 11.70M | 194.05% |
Cash from financing | 43.00K | -78.92% |
Net change in cash | 1.92M | 150.42% |
Free cash flow | -6.20M | -60.95% |
About
Founded
1998
Website
Employees
40